Myomo Q1 revenue $10.1M (+3% YoY); net loss narrows to $3.0M; guides Q2 $10.3M-$10.8M

MYOMO, INC.

2026-Q1 EPS reported -$0.07 vs consensus -$0.12 ▲ beat (+39.2%)

Revenue $10.1M (+3% YoY), net loss $3.0M ($0.07/sh) vs $3.5M loss ($0.08/sh) in Q1 2025.
Gross margin expanded to 68.2% (up 100 bps); operating expenses down 1% YoY to $10.1M.
Orders received 239 (+12% YoY); backlog 226 (+14% vs Dec 2025); pipeline adds up 7% sequentially.
Recurring patient source revenue reached 49% of total, up from 25% a year ago.
Q2 2026 revenue guidance $10.3M-$10.8M; FY 2026 revenue reiterated at $43M-$46M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MYOMO, INC. reported first quarter ended March 31, 2026 results: revenue $10,113,288, net income $3.0 million, EPS $0.07 per share. Guidance reaffirmed.

Period: first quarter ended March 31, 2026
Revenue: $10,113,288
Net income: $3.0 million
EPS: $0.07 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Myomo Reports First Quarter 2026 Financial and Operating Results Revenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year Expanded gross margin, lower operating expenses and narrowed net loss Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (May 7, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2026.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

MYOMO, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-211928

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.